Sign in

CIK 0001130598

  • Non-accelerated filer
  • Smaller reporting company

Traws Pharma, Inc.

Sign in to watch
Ticker
TRAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-759-3680
Business address
12 PENNS TRAIL, NEWTOWN, PA, 18940
Former names
Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 26 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-12-18 Guerin Mark Patrick Chief Accounting Officer Grant or award · Stock Option (right to purchase) +25,000 25,000
2014-07-07 Hoffman Michael B Director Exercise or conversion +18,754 $2.67 $50K 18,754
2014-07-07 Hoffman Michael B Director Exercise or conversion · Stock Option (right to purchase) −18,754 0
2014-05-22 VANLENT ANNE Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2014-05-22 Reddy E Premkumar Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2014-05-22 GROOPMAN JEROME Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2014-05-22 MEHTA VIREN Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2014-05-22 Bienen Henry S Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2014-05-22 Hoffman Michael B Director Grant or award · Stock Option (right to purchase) +13,000 13,000
2014-05-02 Reddy E Premkumar Director Exercise or conversion +27,084 $1.33 $36K 1,337,838
2014-05-02 Reddy E Premkumar Director Exercise or conversion · Common Stock Option (right to buy) −27,084 0
2014-02-21 Michael & Jane Hoffman 2013 Descendants 10% owner Purchase +71,740 $8.91 $639K 4,518,275
2014-02-21 Hoffman Michael B Director Purchase +71,740 $8.91 $639K 4,518,275
2014-02-20 Michael & Jane Hoffman 2013 Descendants 10% owner Purchase +71,740 $8.03 $576K 4,446,535
2014-02-20 Hoffman Michael B Director Purchase +71,740 $8.03 $576K 4,446,535
2014-02-10 Kumar Ramesh President and CEO Exercise or conversion +20,000 $6.00 $120K 296,500
2014-02-10 Kumar Ramesh President and CEO Sale −20,000 $15.11 $302K 276,500
2014-02-10 Kumar Ramesh President and CEO Exercise or conversion · Stock Option (right to buy) −20,000 16,739
2014-02-07 Kumar Ramesh President and CEO Exercise or conversion +13,543 $6.00 $81K 290,043
2014-02-07 Kumar Ramesh President and CEO Exercise or conversion · Stock Option (right to buy) −13,543 36,739

Page 21 of 23 · 449 trades